spacer
home > pmps > summer 2017 > supply uninterrupted
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Supply Uninterrupted

The biopharmaceutical manufacturing sector is adopting new technologies and consumables at a fast pace to meet growth demands and increase flexibility. At the same time, regulatory authorities are putting pressure on biomanufacturers to have control over their full supply chains. Indeed, both manufacturers and industry working groups are placing increased emphasis on raw material and supplier management to help protect patients, enhance transparency and minimise risk (1-4). Additional concerns centre around events that might interrupt the supply of components needed to manufacture human health products.

Some suppliers are responding by investing in strategies, in-house expertise and human and system resources to help biomanufacturers meet these needs, but others are not as responsive. When choosing suppliers, a structured and risk-based approach is important.

A Holistic Approach


Ensuring that materials are available when needed is a key aspect of a supply chain security programme, but it is not sufficient for suppliers to focus on this alone. The products must maintain a high level of quality each time, and any changes must be communicated in a punctual and transparent manner. A comprehensive supply security strategy addresses these needs. One example of a holistic approach is based on three interrelated concepts (see Figure 1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Employed by GE Healthcare since 2001, Elles Steensma is the Global Product Manager for Security of Supply for chromatography resins. Her prior roles at the company include Protein Scientist in R&D and Quality Control Manager within Global Supply Chain. At Wageningen University, The Netherlands, Elles earned a BSc and MSc in molecular sciences as well as a PhD in biochemistry. She joined GE Healthcare after several years as a postdoctoral researcher at Uppsala University, Sweden.
spacer
Elles Steensma
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

NEUWAY Pharma and Cobra Biologics collaborate to develop GMP grade Engineered Protein Capsules (EPCs) manufacturing process

International CDMO of biologics and pharmaceuticals, together with a biopharma company developing drugs for orphan diseases, announce the conclusion of a Service Agreement relating to Engineered Protein Capsules
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

2nd Annual Clinical Trial Supply East Asia

6-7 December 2017, Seoul, South Korea

This is the only event focusing Clinical Trials Supply in Korea. This event focuses on providing discussions to achieve efficient and seamless clinical supply for trials, as well as providing an In-depth overview into the key regulatory challenges faced by companies in the East Asia region. This is a unique event encompassing discussions around strategies to ensure smooth clinical trial supply chain.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement